- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01629004
Increasing Uptake of Colorectal Cancer Screening in Ontario
December 19, 2014 updated by: Sunnybrook Health Sciences Centre
The investigators hope to determine whether the addition of an FOBT kit and educational materials to a second mailed invitation compared to a second mailed invitation alone increases use of appropriate screening tests (FOBT for average risk or colonoscopy if increased risk) by eligible persons within 6 months of the second mailing in: (1)Non-responders to an initial mailed CRC screening invitation from their family physician and, (2)Those who responded to the initial mailed CRC screening invitation and are due for repeat screening (i.e., "recall" patients).
In addition, the investigators will also explore the impact of the investigators intervention in likely under-screened groups such as those living in more remote areas of the province and those with low socio-economic status as well as assessing the cost-effectiveness of this strategy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5155
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada
- Sunnybrook HSC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 74 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Recipients of a mailed CRC screening invitation through the CCO Invitation Pilot project
- No OHIP record of completion of FOBT since initial mailing (Non-responders arm only)
- No OHIP of 'CRC Cancer Screening Exclusion' tracking code since initial mailing (Non-responders arm only)
- An OHIP record of completion of FOBT 6 months since initial mailing (Recall arm only)
- Negative result according to LRT or if not in LRT, no record of interval colonoscopy in CIRT or OHIP (Recall arm only)
Exclusion Criteria:
- Age greater than 74 years at time of mailing
- Interval diagnosis of colorectal cancer
- Interval colonoscopy or flexible sigmoidoscopy
- Interval departure from Pilot physician's practice
- Death
- Presently institutionalized
- Physician has declined participation in the study
- Interval record of repeat FOBT (Recall arm only)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Non-responders
Non-responders to an initial mailed CRC screening invitation from their family physician. FOBT kit. Mailed invitation. |
Mailed FOBT kit with educational materials and mailed CRC screening invitation on behalf of family physician.
Other Names:
Mailed CRC screening invitation alone on behalf of family physician.
Other Names:
|
Other: Recall patients
Those who responded to the initial mailed CRC screening invitation and are now due for repeat screening (i.e., "recall" patients). FOBT kit. Mailed invitation. |
Mailed FOBT kit with educational materials and mailed CRC screening invitation on behalf of family physician.
Other Names:
Mailed CRC screening invitation alone on behalf of family physician.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Uptake of appropriate CRC screening
Time Frame: Within 6 months of the mailing
|
The primary outcome will be the uptake of appropriate screening (FOBT testing or if there is a positive family history, of colonoscopy) within 6 months of the mailing as determined by from OHIP and CCO data.
|
Within 6 months of the mailing
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Uptake of lower gastrointestinal investigations
Time Frame: Within 12 months of the mailing
|
The secondary outcome will be the uptake of lower gastrointestinal investigations (colonoscopy for an indication other than family history or colonoscopy done outside of CIRT, flexible sigmoidoscopy, barium enema) within 12 months, respectively, of the mailing as determined by the administrative data (CIRT, OHIP procedure or radiology code).
|
Within 12 months of the mailing
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jill Tinmouth, MD, Sunnybrook HSC
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
June 25, 2012
First Submitted That Met QC Criteria
June 26, 2012
First Posted (Estimate)
June 27, 2012
Study Record Updates
Last Update Posted (Estimate)
December 23, 2014
Last Update Submitted That Met QC Criteria
December 19, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 308-2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Disorders
-
Gulhane School of MedicineUniversity Hospital, Ghent; Szeged University; University Clinical Centre of... and other collaboratorsCompletedColorectal Disorders | Colorectal SurgeryTurkey
-
Institut Paoli-CalmettesNot yet recruitingColorectal Disorders
-
Leonardo Bustamante-LopezRodrigo Ambar PintoUnknownColorectal DisordersBrazil
-
Katherine DeansSociety of University SurgeonsCompleted
-
Mayo ClinicCompleted
-
Spectrum Health HospitalsRecruitingColorectal DisordersUnited States
-
Karolinska InstitutetCompletedColorectal DisordersEthiopia
-
Taichung Veterans General HospitalCompletedColorectal DisordersTaiwan
-
Russian Society of Colorectal SurgeonsUnknownColorectal DisordersRussian Federation
-
Dr. Liane S. FeldmanSociety of American Gastrointestinal and Endoscopic SurgeonsCompletedColorectal DisordersCanada
Clinical Trials on FOBT kit
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of Health; Bankhead-Coley Cancer Research ProgramCompletedColorectal Cancer | Colorectal CarcinomaUnited States
-
University of California, San FranciscoCenters for Disease Control and Prevention; San Francisco Department of Public...CompletedColorectal CancerUnited States
-
Jonsson Comprehensive Cancer CenterAmerican Cancer Society, Inc.CompletedRectal Cancer | Colon CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedColorectal CancerUnited States
-
University of MiamiRecruitingHypoplastic Left Heart SyndromeUnited States
-
University of MichiganCompleted
-
IdentigeneCRI Lifetree Clinical ResearchUnknown
-
Merck KGaA, Darmstadt, GermanyCompleted
-
South Dakota State UniversityUniversity of Missouri-Columbia; Ohio State University; Michigan State University and other collaboratorsCompletedFood Security | Nutritive Value
-
Shandong UniversityCompletedColorectal CancerChina